U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H18ClN3S2
Molecular Weight 351.917
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CNS-5161

SMILES

CSC1=CC=CC(=C1)N(C)C(=N)NC2=C(Cl)C=CC(SC)=C2

InChI

InChIKey=JHVHEDNLONERHY-UHFFFAOYSA-N
InChI=1S/C16H18ClN3S2/c1-20(11-5-4-6-12(9-11)21-2)16(18)19-15-10-13(22-3)7-8-14(15)17/h4-10H,1-3H3,(H2,18,19)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Early clinical experience with the novel NMDA receptor antagonist CNS 5161.
2002 Mar
In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain.
2007 Aug
Name Type Language
CNS-5161
Common Name English
CNS 5161
Common Name English
GUANIDINE, N'-(2-CHLORO-5-(METHYLTHIO)PHENYL)-N-METHYL-N-(3-(METHYLTHIO)PHENYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
58S83M36V6
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
DRUG BANK
DB05824
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
SMS_ID
100000127558
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
PUBCHEM
192711
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
ChEMBL
CHEMBL41306
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
EPA CompTox
DTXSID20166975
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
EVMPD
SUB33591
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY
CAS
160754-76-7
Created by admin on Fri Dec 15 17:58:25 UTC 2023 , Edited by admin on Fri Dec 15 17:58:25 UTC 2023
PRIMARY